Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint.
Shetzline
Michael A
MA
Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA. michael.shetzline@novartis.com
Cohard-Radice
Marielle
M
Joelsson
Bo
B
D017091:Colitis, Ischemic / Q000139:chemically induced*; D003248:Constipation / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*
D007211:Indoles; C105050:tegaserod